These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3565431)

  • 1. Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia.
    Thiébaud D; Burckhardt P; Jaeger P; Azria M
    Am J Med; 1987 Apr; 82(4):745-50. PubMed ID: 3565431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
    Thiébaud D; Jacquet AF; Burckhardt P
    Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of rectal and nasal administration of salmon calcitonin in normal subjects.
    Buclin T; Randin JP; Jacquet AF; Azria M; Attinger M; Gomez F; Burckhardt P
    Calcif Tissue Int; 1987 Nov; 41(5):252-8. PubMed ID: 3121149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy.
    Fatemi S; Singer FR; Rude RK
    Calcif Tissue Int; 1992 Feb; 50(2):107-9. PubMed ID: 1571826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
    Adachi I; Kimura S; Yamaguchi K; Suzuki M; Abe K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man.
    Nilsson O; Almqvist S; Karlberg BE
    Acta Med Scand; 1978; 204(4):249-52. PubMed ID: 358762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy.
    Binstock ML; Mundy GR
    Ann Intern Med; 1980 Aug; 93(2):269-72. PubMed ID: 7406378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmon calcitonin in hypercalcemia.
    Wisneski LA; Croom WP; Silva OL; Becker KL
    Clin Pharmacol Ther; 1978 Aug; 24(2):219-22. PubMed ID: 567108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmon calcitonin in the acute management of hypercalcemia.
    Wisneski LA
    Calcif Tissue Int; 1990; 46 Suppl():S26-30. PubMed ID: 2137363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
    Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
    Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furosemide, mithramycin, and salmon calcitonin in hypercalcemia.
    Filastre JP; Humbert G; Leroy J; Maitrot J; Deshayes P; Canonne MA
    Eur J Intensive Care Med; 1975 Dec; 1(4):185-8. PubMed ID: 130239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmon calcitonin in the treatment of hypercalcemia.
    Silva OL; Becker KL
    Arch Intern Med; 1973 Sep; 132(3):337-9. PubMed ID: 4798763
    [No Abstract]   [Full Text] [Related]  

  • 15. [Two cases of malignancy-associated hypercalcemia from bone metastases of breast cancer successfully treated with combination therapy using pamidronate and calcitonin].
    Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):763-6. PubMed ID: 10832449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin therapy in prolonged immobilization hypercalcemia.
    Carey DE; Raisz LG
    Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
    Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM; Tuel SM; Cross LL
    Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.
    Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
    J Clin Oncol; 1988 May; 6(5):762-8. PubMed ID: 3367184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.